Amneal Pharmaceuticals, Inc. has agreed to a nationwide opioids settlement, paying $88.5 million and providing naloxone valued at up to $177.4 million, effective January 29, 2026. This settles most claims from states and subdivisions related to opioids, with the option for cash alternatives totaling up to $132.9 million.